We are a company formed by the union of nonconformists. On the one hand, scientists who seek to discover who Brazilians really are and, on the other hand, entrepreneurs and investors who understand the value of this discovery for the country. While other countries in the world are advancing in the sequencing of the DNA of their population, Brazil is still behind. Traditional paths to the evolution of science do not advance. And we are the ones who lose out, because important traits that may be hidden in our genome are no longer identified, putting Brazilians outside the so-called precision medicine. Gen-t was created to be a platform capable of including Brazil on the map of genomic research. Understanding our origins is the only path to full development. Knowing our identity, we will be able to develop more effective medicines and treatments for our diseases and verify that Brazil is, in fact, one of the countries with the greatest genetic diversity in the world.
| Website | https://gen-t.science/ |
| Employees | 32 (21 on RocketReach) |
| Founded | 2021 |
| Industry | Research Services |
| Keywords | Genome Analysis, Genomics Research, Biomedical Research, Pharmaceutical Research, Biotechnology, Scientific Discovery, Data Analytics, Health Research, Genetic Diversity, Precision Medicine, Human Genetics, Scientific Innovation, Life Sciences, Genetic Testing, Healthcare Technology, Bioinformatics, Medical Research, Dna Sequencing |
| Competitors | Genentech, Amgen, Regeneron, Gilead Sciences, Illumina, Moderna Therapeutics, bluebird bio, CureVac, Editas Medicine, Sangamo Therapeutics, Inc. +40 more (view full list) |
Looking for a particular gen-t employee's phone or email?
Lygia Pereira is the CEO of gen-t.
21 people are employed at gen-t.